(Q54907502)

English

NB-1691

cell line

NB1691
NB 1691

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.

1 reference

Cellosaurus release 49

14 July 2024

Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.

1 reference

Cellosaurus release 49

14 July 2024

Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status

1 reference

Cellosaurus release 49

14 July 2024

Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11

1 reference

Cellosaurus release 49

14 July 2024

Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

unknown value

2 references

Cellosaurus release 44

23 January 2023

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/BTO_0002834

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54907502&oldid=2258425727"